Skip to main content

Table 4 Comparison of demographics and comorbidities between with and without diagnostic ureteroscopy in patients with upper tract urothelial carcinoma

From: The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence

 

URS+

URS-

P-value

Mean±SD/ (N,%)

Mean±SD/ (N,%)

 

3,079 (53.9)

2,634 (46.1)

 

Gender

 Male (N, %)

1,346 (43.72%)

1,126 (42.75%)

0.462

 Female (N, %)

1,733 (56.28%)

1,508 (57.25%)

 

Age (Mean±SD)

67.79 (±10.68)

67.63 (±11.15)

0.599

Age (N,%)

 <65 years

1,092 (35.47%)

952 (36.14%)

0.491

 65-74 years

1,150 (37.35%)

944 (35.84%)

 

 >74 years

837 (27.18%)

738 (28.02%)

 

CCI score (N,%)

 0

272 (8.83%)

341 (12.95%)

<0.001*

 1

217 (7.05%)

245 (9.30%)

 

 ≧2

2,590 (84.12%)

2,048 (77.75%)

 

Comorbidity

 Hypertension

  No

1,443 (46.87%)

1,300 (49.35%)

0.061

  Yes

1,636 (53.13%)

1,334 (50.65%)

 

 Hyperlipidemia

  No

2,371 (77.01%)

2,138 (81.17%)

<0.001*

  Yes

708 (22.99%)

496 (18.83%)

 

 Diabetes

  No

2,345 (76.16%)

2,054 (77.98%)

0.103

  Yes

734 (23.84%)

580 (22.02%)

 

 ESRD

  No

2,490 (80.87%)

2,072 (78.66%)

0.038*

  Yes

589 (19.13%)

562 (21.34%)

 
  1. CCI Charlson Comorbidity Index, ESRD End-stage renal disease
  2. *p<0.05